Atlas Trials

Real World Evidence of the Effectiveness of Paritaprevir/r - Ombitasvir, ± Dasabuvir, ± Ribavirin in Participants With Chronic Hepatitis C

Clinical trial NCT02725866 · COMPLETED

Trial details

NCT number
NCT02725866
Sponsor
AbbVie
Status
COMPLETED
Study type
OBSERVATIONAL
Chronic Hepatitis C
Start date
2016-04-05
Primary completion
2017-10-31
Enrollment
216

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.